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Abstract SV40 large tumor-antigen (T-ag) nuclear import is
enhanced by the protein kinase CK2 (CK2) site (Ser111Ser112)
flanking the nuclear localization sequence (NLS). Here we use
site-directed mutagenesis to examine the influence of negative
charge and conformation at the site on T-ag nuclear import and
recognition by the NLS-binding importin subunits. Negative
charge through aspartic acid in place of Ser111 simulated CK2
phosphorylation in enhancing nuclear accumulation to levels well
above those of proteins lacking a functional CK2 site. This was
shown to be through enhancement of T-ag NLS recognition by
importin using an ELISA-based assay. Asp112-substituted
mutants containing proline at positions 109, 110 (wild-type
position) or 111 were compared to assess the role of conforma-
tion at the CK2 site. Maximal nuclear import of the protein with
Pro109 was lower than that of the Pro110 derivative, with the
Pro111 variant even lower, these differences also being attribut-
able to effects on importin binding. All results indicate a
correlation of the initial nuclear import rate with the importin
binding affinity, demonstrating that NLS recognition by
importin is a key rate-determining step in nuclear import.
z 1998 Federation of European Biochemical Societies.




The ¢rst step of nuclear localization sequence (NLS)-de-
pendent nuclear protein import involves recognition of the
NLS-containing protein by a heterodimeric complex compris-
ing importin (karyopherin) K and L (importin 58 and 97) [1,2].
The NLS is bound speci¢cally by importin K [3], followed by
targeting to the nuclear envelope-localized nuclear pore com-
plex (NPC) through importin L’s ability to bind to speci¢c
NPC components [4,5]. The subsequent step of translocation
into the nucleus through the NPC is an energy-dependent
process requiring the monomeric GTP-binding protein Ran
[6,7] and other modifying factors.
Although the NLS is an essential determinant for the nu-
clear entry of most proteins of 45 kDa or greater [8^10], NLS-
dependent nuclear import of many proteins has been shown to
be regulated by phosphorylation [11,12]. The protein kinase
CK2 (CK2) site (Ser111Ser112) £anking the NLS of simian
virus SV40 large tumor-antigen (T-ag), for example, enhances
the rate of nuclear import of T-ag fusion proteins 50-fold [13].
That CK2 may have a more general role in regulating protein
nuclear transport is indicated by the fact that many other
proteins contain consensus CK2 sites in the vicinity of their
respective NLSs [12]; of these, the Xenopus nuclear phospho-
protein nucleoplasmin has also been reported to exhibit CK2
enhancement of the nuclear import rate in microinjected oo-
cytes [14]. Using an enzyme-linked immunosorbent assay
(ELISA) assay to determine importin-NLS binding, we have
recently demonstrated that the enhancement of T-ag nuclear
import by the CK2 site is through modulation of importin
binding to the T-ag NLS [15]. Whilst phosphorylation at the
CK2 site increases the a⁄nity of importin binding [15,16],
altering the position of the CK2 site relative to the T-ag
NLS reduces importin binding [15].
In this study, we use site-directed mutagenesis to examine
the importance to T-ag nuclear import of negative charge and
conformation at the CK2 site. Ser111 was substituted by as-
partic acid, resulting in maximal nuclear accumulation about
50% that of the wild-type protein, much higher than that for
proteins lacking a functional CK2 site [17]. Negative charge at
position 111 can thus simulate phosphoserine at this site to
enhance T-ag nuclear import in similar fashion to negative
charge at position 112 [17]. Using an ELISA-based assay
[15,16], this e¡ect was demonstrated for the ¢rst time to be
through modulation of importin binding to the T-ag NLS. To
assess the e¡ects of conformation at the CK2 site on T-ag
importin binding and nuclear import, a series of mutants
was constructed containing proline at either position 109,
110 (wild-type position) or 111 in the context of negative
charge at the CK2 site through Asp112. Maximal nuclear ac-
cumulation of the Pro109 derivative was lower than that of the
protein with Pro110, whilst that of the Pro111 variant was even
lower. These e¡ects were shown to be through e¡ects on the
binding of importin to the T-ag NLS. All results indicate a
correlation between the nuclear import rate and a⁄nity of
NLS recognition by importin, demonstrating that the latter
is a key rate-determining step in nuclear import.
2. Materials and methods
2.1. Chemicals
Isopropyl-L-D-thiogalactopyranoside (IPTG) was from Boehringer
Mannheim, p-nitrophenyl phosphate from Sigma, and the sulfhydryl
labelling reagent 5-iodoacetamido£uorescein (IAF) from Molecular
Probes. Other reagents were from the sources described previously
[15,18^20].
2.2. Plasmid constructs encoding T-ag fusion proteins
All of the T-ag L-galactosidase (L-gal) fusion proteins used in this
study contain T-ag amino acid residues 111^135 (see Table 1) or
variants thereof, fused N-terminal to the Escherichia coli L-galactosi-
dase sequence (amino acids 9^1023; EC 3.2.1.23.37) [13,19,21]. Plas-
mids pPR16 and pDAJ10, encoding the wild-type T-ag fusion protein
CcN-L-Gal and its derivative D2cN-L-Gal which contains
Gly111Asp112 in place of Ser111=112 (see Table 1), have been described
previously [13,17,19]. Plasmid pCYX1 encoding T-ag fusion protein
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D1cN-L-Gal with Asp111Ala112 in place of the CK2 site Ser111=112 of
the wild-type T-ag fusion protein was generated from plasmid
pDAJ10 [17] using oligonucleotide site-directed mutagenesis (Clontech
Transformer Kit) [15,22]. Plasmid M13DAJ2 [17] was used for site-
directed mutagenesis to generate plasmids pDAJ11 and pDAJ13, en-
coding T-ag fusion proteins D3cN-L-Gal and D4cN-L-Gal which con-
tain Pro109 and Pro111, respectively, together with Asp112 (see Table 1
for amino acid sequences). In the case of plasmid pDAJ13, a Sau3A
restriction site was inserted at amino acids 110/111, enabling isolation
of the mutated 101-bp Sau3A fragment, which was then ¢lled-in with
Klenow, followed by the addition of 10-mer EcoRI linkers into
EcoRI-partially digested plasmid pPR2 [17,19]. In the case of plasmid
pDAJ11, the 5P-overhanging ends were digested with Mung bean nu-
clease, followed by the ligation of 10-mer SmaI linkers into the SmaI
site of plasmid pPR2 [17,19]. The integrity of all constructs was con-
¢rmed by DNA sequencing.
2.3. Fusion protein expression, puri¢cation and labelling
Induction of fusion protein expression in E. coli using IPTG, pro-
tein puri¢cation by a⁄nity chromatography, and IAF labelling were
all performed as described previously [13,17].
2.4. Cell culture
Cells of the HTC rat hepatoma tissue culture cell line (a derivative
of Morris hepatoma 7288C) were cultured in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% foetal calf serum [13,21].
2.5. Nuclear import kinetics
Analysis of nuclear import kinetics at the single cell level using
microinjected HTC cells in conjunction with confocal laser scanning
microscopy (CLSM; Bio-Rad MRC-600) was as described previously
[13,17,19,21]. HTC cells were fused with polyethylene glycol at least
1 h prior to microinjection to produce polykaryons [13,19]. Image
analysis of CLSM ¢les using the NIH Image public domain software,
and curve ¢tting were performed as described [18,22].
2.6. Expression of mouse importin 58- and 97-fusion proteins
Expression in E. coli of mouse importin 58-glutathione-S-transfer-
ase (GST) or 97-GST [2] was induced with IPTG, and GST fusion
proteins puri¢ed and GST-free mouse importin 58 prepared by throm-
bin cleavage as described previously [15].
2.7. ELISA-based binding assay
Binding of importin subunits to T-ag fusion proteins was quanti-
tated using an ELISA-based assay [15,16]. Brie£y, fusion proteins
were coated into microtiterplates and incubated with increasing dilu-
tions of precomplexed importin 58/97-GST complex. Bound importin
was detected using GST-speci¢c primary and alkaline phosphatase-
conjugated secondary antibodies, followed by incubation with the
colorimetric substrate p-nitrophenyl phosphate. The change of ab-
sorbance at 405 nm was followed for 90 min using a plate reader
(Molecular Devices), with values corrected by subtracting both the
absorbance at 0 min, and the absorbance in wells incubated without
importin. T-ag fusion proteins were also subjected to a parallel L-
galactosidase ELISA assay (see [15,16,23]) to correct for any di¡er-
ences in coating e⁄ciencies and enable a true estimate of bound im-
portin using a L-galactosidase speci¢c monoclonal antibody as de-
scribed [15,16,23].
3. Results
3.1. Aspartic acid at position 111 within the CK2 site enhances
T-ag nuclear import
Site-directed mutagenesis was used to substitute Ser111 of
the T-ag CK2 site with aspartic acid in the context of the non-
phosphorylatable Ala residue at position 112 (see Section 2),
and the kinetics of nuclear import measured (Fig. 1, Table 1).
Aspartic acid at position 111 (protein D1cN-L-Gal; see Table
1 for the T-ag sequences of the fusion proteins) enhanced
nuclear accumulation compared to proteins lacking a func-
tional CK2 site [17]. Maximal nuclear accumulation of
D1cN-L-Gal was about 50% that of the wild-type protein
with a functional CK2 site (Fig. 1 and Table 1), comparable
to that of D2cN-L-Gal containing aspartic acid in place of
Ser112 at the CK2 site (Fig. 1; see also [17]). In the case of
both D1cN-L-Gal and D2cN-L-Gal [17], the introduced neg-
ative charge simulates phosphoserine at the CK2 site in the
wild-type protein meaning that negative charge at either Ser111
or Ser112 can function to enhance nuclear import, consistent
with the ability of both to be phosphorylated by CK2 [17],
and facilitate nuclear import in the absence of the other (see
[13]). The fact that the initial nuclear import rate of both
D1cN-L-Gal and D2cN-L-Gal is comparable to that of the
wild-type protein (Fig. 1 and Table 1) is consistent with the
idea that negative charge at the CK2 site increases the T-ag
transport rate [13].
3.2. Conformation at the CK2 site a¡ects T-ag nuclear import
kinetics
To assess the importance of conformation at the CK2 site,
site-directed mutagenesis was used to generate a series of mu-
tants containing proline at either position 109, 110 (the wild-
type position) or 111, in the context of negative charge at the
CK2 site through Asp112 (see Table 1 for sequence details).
The nuclear import kinetics of D2cN-L-Gal (Pro110), D3cN-L-
Gal (Pro109) and D4cN-L-Gal (Pro111) were compared, max-
imal accumulation of all three being higher than that of pro-
teins with non-functional or deleted CK2 sites (see [13,17]),
again consistent with the idea that Asp at the CK2 site can
enhance T-ag nuclear import (Fig. 1). The maximal nuclear
accumulation of the fusion proteins D3cN-L-Gal and D4cN-
L-Gal, however, was about 30 and 50% lower than that of
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Table 1
In vivo nuclear import kinetics and NLS binding by mouse importin 58/97 of T-ag fusion proteins
Fusion proteina T-ag sequenceb Nuclear import parameterc Binding a⁄nityd
(CK2 site^NLS) Initial ratee Bmax relative to wild type KD
Fn=c/min (n) Fn/cmax
CcN-L-Gal P110SSDDEATADSQHSTPPKKKRKV132 1.14 þ 0.27 (4) 5.9 þ 0.20 100 6.55 þ 0.2
D1cN-L-Gal P110daDDEATADSQHSTPPKKKRKV132 0.95 þ 0.18 (8) 2.8 þ 0.10 94 þ 4 12.20 þ 1.1
D2cN-L-Gal P110gdDDEATADSQHSTPPKKKRKV132 1.07 þ 0.30 (8) 3.6 þ 0.20 90 þ 2 12.20 þ 0.1
D3cN-L-Gal p109ggdDDEATADSQHSTPPKKKRKV132 0.77 þ 0.08 (5) 2.4 þ 0.10 110 þ 19 16.65 þ 1.9
D4cN-L-Gal p111 dDDEATADSQHSTPPKKKRKV132 0.66 þ 0.06 (4) 1.9 þ 0.02 100 þ 21 24.85 þ 7.1
aAll fusion proteins contain T-ag sequences fused amino-terminal to E. coli L-galactosidase (amino acids 9^1023).
bThe single letter amino acid code is used, with wild-type T-ag residues shown in capital letters. The CK2 site is bold and underlined, and the NLS
double underlined; the CK2 site aspartic acid residues are shown in bold type.
cRaw data (see Fig. 1B and not shown) from at least four experiments were ¢tted as described in Section 2.
dValues represent the mean þ S.E.M. for four separate experiments (see Fig. 2).
eInitial nuclear import rates were calculated from data (see Fig. 2) up to 3 min after microinjection [22].
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Fig. 1. In£uence of mutations at the CK2 site on nuclear import kinetics of T-ag fusion protein derivatives in vivo. A: CLSM images show
HTC polykaryons about 13 min after microinjection with T-ag fusion proteins. B: Nuclear import was measured in vivo in HTC cells using
CLSM and image analysis as described in Section 2. The measurements represent the average of at least four separate experiments, where each
point represents the average of 6^10 separate measurements for each of nuclear (Fn) and cytoplasmic (Fc) £uorescence, respectively, with auto-
£uorescence subtracted. Curves were ¢tted for the function Fn=c(t)=Fn/cmax (13e3kt ) [13,15,18], where Fn/cmax is the maximal nuclear accumula-
tion level, k is the nuclear import rate constant, and t is time in minutes.
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D2cN-L-Gal, respectively, and the initial import rates of
D3cN-L-Gal and D4cN-L-Gal about 70 and 60% lower, re-
spectively (Fig. 1B and Table 1). The di¡erent position of
proline relative to the Asp112 presumably alters conformation
at the CK2 site suggesting that the precise position of the
CK2 site is important for NLS recognition [15].
3.3. Importin binding properties of proteins containing Asp at
the CK2 site
To test whether the above results could be understood in
terms of e¡ects on NLS recognition, the Asp containing pro-
teins were tested for recognition by the NLS-binding importin
58/97 heterodimer using an ELISA-based assay [15,16]. The
KDs (apparent dissociation constants [15]) of D1cN-L-Gal and
D2cN-L-Gal with Asp111 or Asp112, respectively, were about
two times higher than that of the wild-type protein (Fig. 2, left
panel, and Table 1), implying that decreased a⁄nity of im-
portin for the T-ag NLS is the basis of their reduced nuclear
import compared to wild type. Interestingly the KD of the
protein derivatives with either Pro109 or Pro111 was further
increased compared to D2cN-L-Gal with proline at the wild-
type position (110) (Fig. 2, right panel, and Table 1). This
implies that alteration of the position of proline relative to
Asp112 modulates T-ag nuclear protein import (Fig. 1 and
Table 1) through e¡ects on NLS recognition by importin
58/97; proline presumably changes precise conformation at
the CK2 site, thereby impairing T-ag interaction with impor-
tin 58/97. This is consistent with the idea [15,16] that the CK2
site participates directly in T-ag NLS/importin recognition
[16] by interacting directly with the importin 58 subunit.
4. Discussion
This study is the ¢rst investigation of the in£uence on T-ag
nuclear import of conformation in the context of negative
charge at the CK2 site. Substitution of Ser111 by aspartic
acid results in nuclear import well above that of proteins
lacking a functional CK2 site [13,17,19], similar to the e¡ect
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Fig. 2. In£uence of mutations at the CK2 site on T-ag NLS binding by importin 58/97. Microtiterplates coated with fusion proteins (0.5 Wg/
well) were hybridised with increasing amounts of mouse importin 58/97 as described in Section 2. Curves were ¢tted for the function
B(x) = Bmax (13e3kB), where x is the concentration of importin [15,16]. The results are from a single typical experiment representative of four
separate experiments. Pooled data are shown in Table 1.
Fig. 3. Correlation between the a⁄nity of NLS recognition by im-
portin 58/97 and initial nuclear import rate of T-ag fusion proteins.
Data were calculated from the data in Table 1; R is the regression
coe⁄cient.
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of Asp112 [17]. This indicates that negative charge at either 111
or 112 can simulate phosphoserine at the CK2 site in terms of
enhancement of nuclear import. The fact that the initial nu-
clear import rate of these two mutant proteins is comparable
to that of the wild-type fusion protein supports the impor-
tance of negative charge at the CK2 site in accelerating T-
ag nuclear import. That the a⁄nity of T-ag NLS recognition
by the importin subunits in the case of D1cN-L-Gal or D2cN-
L-Gal is much higher than that of proteins lacking a func-
tional CK2 site (see [15]) demonstrates directly that negative
charge at the CK2 site, normally produced by phosphoserine,
is important in NLS binding by importin 58/97 (see [16]). This
study shows that the position of proline relative to the CK2
site also in£uences T-ag nuclear import by a¡ecting the bind-
ing of importin to the T-ag NLS. Proline imposes strong re-
straints on protein conformation [24] through its cyclic struc-
ture, which limits the angle of rotation about the K-carbon
and nitrogen within a peptide bond and introduces a ¢xed
bend into the peptide chain [25,26]. This study shows that
moving proline either closer to or further away from the
CK2 site alters recognition of the T-ag NLS by importin
and in turn in£uences the nuclear import kinetics. Clearly,
precise conformation at the CK2 site a¡ects interaction with
importin, supporting the idea that the CK2 is directly in-
volved in importin binding (see [16]).
All of the results of this study strongly imply a correlation
between the nuclear import rate and importin binding a⁄nity.
This is borne out by plotting the KDs of the various T-ag
derivatives described here against their initial rates of nuclear
import, relative to that of the wild-type protein (CcN-L-Gal)
(Fig. 3), to reveal a direct correlation (R = 0.945). The initial
import rate is thus directly dependent on the a⁄nity of the
NLS interaction with importin (see [15]), with the results of
our recent study comparing the T-ag NLS and the bipartite
NLS of Rb (retinoblastoma protein) with respect to NLS
binding a⁄nity and nuclear import kinetics [23] consistent
with this idea. The a⁄nity of binding to importin 58/97 is
thus the major determinant of the initial transport rate, im-
plying that NLS recognition and binding by importin in the
cytoplasm is a key limiting event for nuclear import. The high
importin binding a⁄nity in the case of T-ag with negative
charge at the CK2 site presumably results in more rapid ki-
netics of association of importin with T-ag, and faster docking
at the NPC, leading to an accelerated rate of transport.
Aspartic acid-containing phosphorylation-regulated NLSs
(prNLSs; [11,12]), such as those described here with intrinsic,
high a⁄nity for importin, can be regarded as constitutively
active prNLSs where phosphorylation is not required to en-
hance nuclear import. Since they can confer e⁄cient nuclear
entry on other molecules, they may be of use as targeting
signals to facilitate the directed transport of DNA molecules
encoding a gene of interest to the nucleus of relevant cells in
gene therapy or other applications [27]. Alternatively, engi-
neered prNLSs can be used in drug delivery where the ther-
apeutic agent in question has its speci¢c target site of action
within the nucleus (see [28]). Work to test the use of such
constitutive prNLSs in molecular targeting is currently in
progress.
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